GMIM
VRTX icon

General Motors Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

General Motors Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,783
Closed -$212K – 1033
2014
Q4 		$212K Buy
+1,783
New +$201K 0.02% 808
2013
Q4 		– Sell
-4,091
Closed -$310K – 1000
2013
Q3 		$310K Buy
+4,091
New +$326K 0.03% 601

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

General Motors Investment Management's VRTX Position: Q1 2015 in Review

General Motors Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2015, closing a stake of 1,783 shares — an estimated $212K sold.

General Motors Investment Management first reported a position in VRTX in Q3 2013 and held it in 2 quarters. The position peaked at $310K in Q3 2013. 480 funds tracked by Wall St. Rank hold VRTX as of Q1 2015.

  • General Motors Investment Management reported no remaining Vertex Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • General Motors Investment Management sold 1,783 Vertex Pharmaceuticals shares in Q1 2015, an estimated $212K.
  • General Motors Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • General Motors Investment Management's Vertex Pharmaceuticals position peaked at $310K in Q3 2013.
  • 480 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2015.

Based on General Motors Investment Management's 13F filing for Q1 2015, filed 6 May 2015.